MedTrace Logo

Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer

NCT04175067 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 117

Last updated 2019-11-22

No results posted yet for this study

Summary

The purpose of this study is to investigate thiol-disulfide balance in early stage endometrium cancer patients.

Conditions

  • Endometrium Cancer
  • Oxidative Stress

Interventions

DIAGNOSTIC_TEST

Disulphide(μmol/L)

Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with sphectrophotometry

DIAGNOSTIC_TEST

Total Oxidant Capacity(μmolH2O2Equiv/L)

Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with sphectrophotometry

Sponsors & Collaborators

  • Muğla Sıtkı Koçman University

    lead OTHER

Principal Investigators

  • Burak Sezgin · Mugla Sıtkı Kocman University Faculty of Medicine

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2019-10-31
Completion
2019-11-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04175067 on ClinicalTrials.gov